-
News
NanoViricides Completes Oral Gummies and Lung Inhalation Formulations Development for its Non-Mutagenic, Safe, Broad-Spectrum COVID-19 Clinical Drug Candidate, NV-CoV-2
Shelton, Connecticut — (November 15, 2021) – NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), a leader in the development of highly…
Read More » -
Adults with acute heart failure benefit when treated with a type 2 diabetes medication
[ad_1] Research Highlights: When treated with empagliflozin, adults hospitalized for acute heart failure were 36% more likely to have a…
Read More » -
Stem cell therapy for heart failure reduced major CV events and death, not hospitalization
[ad_1] Research Highlights: Adults with chronic, class II or III heart failure with reduced ejection fraction (HFrEF), as defined by…
Read More » -
Blood thinners may prevent cognitive decline in older patients with atrial fibrillation
[ad_1] Research Highlights: A randomized, multi-center, international trial found that when adequately used, prescribed at the correct dosage and taken…
Read More » -
Repair of tricuspid valve leak during mitral valve surgery may benefit some adults
[ad_1] Research Highlights: A leak in the mitral valve can lead to leaking of the tricuspid valve. When the tricuspid…
Read More »